Assessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: A systematic review

Disability and Rehabilitation

Volumn 34, Issue 2, 2012, Pages 91-100

  Phadke, Chetan P ^a,b   Ismail, Farooq ^a,b   Boulias, Chris ^a,b  

^a WEST PARK HEALTHCARE CENTRE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Botulinum toxin; EMG; Neurophysiology; Reflex; Spasticity

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN;

ADULT; DRUG EFFECT; ELECTROMYOGRAPHY; ELECTROSTIMULATION; HUMAN; INNERVATION; LEG; NEUROPHYSIOLOGY; PATHOPHYSIOLOGY; REVIEW; SKELETAL MUSCLE; SPASTICITY;

ADULT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; HUMANS; LOWER EXTREMITY; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEUROPHYSIOLOGY;

EID: 82955247038     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2011.591882     Document Type: Review

References (71)

1. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworthscale of muscle spasticity. Phys Ther 1987;67:206-207. (Pubitemid 17026064)
2. Fleuren JF, Voerman GE, Erren-Wolters CV, Snoek GJ, Rietman JS,Hermens HJ, Nene AV. Stop using the Ashworth Scale for the assessmentof spasticity. J Neurol Neurosurg Psychiatr 2010;81:46-52.
3. Alibiglou L, Rymer WZ, Harvey RL, Mirbagheri MM. The relationbetween Ashworth scores and neuromechanical measurements ofspasticity following stroke. J Neuroeng Rehabil 2008;5:18.
4. Duchen LW, Strich SJ. The effects of botulinum toxin on the patternof innervation of skeletal muscle in the mouse. Q J Exp Physiol CognMed Sci 1968;53:84-89.
5. Voerman GE, Gregoric M, Hermens HJ. Neurophysiological methodsfor the assessment of spasticity: The Hoffmann reflex, the tendon reflex,and the stretch reflex. Disabil Rehabil 2005;27:33-68. (Pubitemid 40136480)
6. Lefaucheur JP. [Electrophysiological assessment of reflex pathways involvedin spasticity]. Neurochirurgie 2003;49:205-214.
7. Matsumoto H, Ugawa Y. Clinical signs, neurophysiological evaluation,and medication of spasticity-review. Brain Nerve 2008;60:1409-1414.
8. Gracies JM. Physiological effects of botulinum toxin in spasticity. MovDisord 2004;19 Suppl 8:S120-S128.
9. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscleoveractivity. Muscle Nerve 2005;31:552-571.
10. Abbruzzese G, Berardelli A. Neurophysiological effects of botulinumtoxin type A. Neurotox Res 2006;9:109-114.
11. Currà A, Trompetto C, Abbruzzese G, Berardelli A. Central effectsof botulinum toxin type A: Evidence and supposition. Mov Disord2004;19 Suppl 8:S60-S64. (Pubitemid 38967513)
12. Frasson E, Priori A, Ruzzante B, Didonè G, Bertolasi L. Nerve stimulationboosts botulinum toxin action in spasticity. Mov Disord2005;20:624- 629. (Pubitemid 40862264)
13. Finsterer J, Fuchs I, Mamoli B. Automatic EMG-guided botulinumtoxin treatment of spasticity. Clin Neuropharmacol 1997;20:195-203. (Pubitemid 27242357)
14. Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH.Ankle muscle activity before and after botulinum toxin therapy forlower limb extensor spasticity in chronic hemiparetic patients. Stroke1996;27:455-460. (Pubitemid 26081442)
15. Kirazli Y, On AY, Kismali B, Aksit R. Comparison of phenol block andbotulinus toxin type A in the treatment of spastic foot after stroke: A randomized,double-blind trial. Am J Phys Med Rehabil 1998;77:510-515. (Pubitemid 29001994)
16. Palmer DT, Horn LJ, Harmon RL. Botulinum toxin treatment of lumbricalspasticity: A brief report. Am J Phys Med Rehabil 1998;77:348-350. (Pubitemid 28377952)
17. Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, BarnesMP. Are we underestimating the clinical efficacy of botulinum toxin(type A)? Quantifying changes in spasticity, strength and upper limbfunction after injections of Botox to the elbow flexors in a unilateralstroke population. Clin Rehabil 2002;16:654-660.
18. Bhakta BB, O'Connor RJ, Cozens JA. Associated reactions after stroke:A randomized controlled trial of the effect of botulinum toxin type A.J Rehabil Med 2008;40:36-41. (Pubitemid 351200731)
19. Cousins E, Ward AB, Roffe C, Rimington LD, Pandyan AD. Quantitativemeasurement of poststroke spasticity and response to treatment withbotulinum toxin: A 2-patient case report. Phys Ther 2009;89:688-697.
20. Mayer NH, Whyte J, Wannstedt G, Ellis CA. Comparative impact of2 botulinum toxin injection techniques for elbow flexor hypertonia.Arch Phys Med Rehabil 2008;89:982-987. (Pubitemid 351618387)
21. Manganotti P, Acler M, Formaggio E, Avesani M, Milanese F, BaraldoA, Storti SF, et al. Changes in cerebral activity after decreasedupper-limb hypertonus: An EMG-fMRI study. Magn Reson Imaging2010;28:646-652.
22. Albani G, Cimolin V, Galli M, Vimercati S, Bar D, Campanelli L, GandolfiR, et al. Use of surface EMG for evaluation of upper limb spasticityduring botulinum toxin therapy in stroke patients. Funct Neurol2010;25:103-107.
23. On AY, Kirazli Y, Kismali B, Aksit R. Mechanisms of action of phenolblock and botulinus toxin Type A in relieving spasticity: Electrophysiologicinvestigation and follow-up. Am J Phys Med Rehabil 1999;78:344-349. (Pubitemid 29331149)
24. Pauri F, Boffa L, Cassetta E, Pasqualetti P, Rossini PM. Botulinumtoxin type-A treatment in spastic paraparesis: A neurophysiologicalstudy. J Neurol Sci 2000;181:89-97.
25. Panizza M, Castagna M, di Summa A, Saibene L, Grioni G, Nilsson J.Functional and clinical changes in upper limb spastic patients treatedwith botulinum toxin (BTX). Funct Neurol 2000;15:147-155.
26. Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Roberto ML, PiccioloG, Macaione V, et al. Botulinum toxin in upper limb spasticity:study of reciprocal inhibition between forearm muscles. Neuroreport1997;8:3039-3044. (Pubitemid 27421728)
27. Miscio G, Del Conte C, Pianca D, Colombo R, Panizza M, SchieppatiM, Pisano F. Botulinum toxin in post-stroke patients: Stiffness modificationsand clinical implications. J Neurol 2004;251:189-196. (Pubitemid 38221633)
28. Mania S, Reza AG, Alfazli RA, Hossein AH. Evaluation of plantar flexormuscles spasticity after the BTXA injection in hemiplegic patientsusing electrophysiological tests. Pejouhandeh 2005;10:191-195.
29. Trompetto C, Bove M, Avanzino L, Francavilla G, Berardelli A, AbbruzzeseG. Intrafusal effects of botulinum toxin in post-stroke upperlimb spasticity. Eur J Neurol 2008;15:367-370. (Pubitemid 351422386)
30. Manca M, Merlo A, Ferraresi G, Cavazza S, Marchi P. Botulinum toxintype A versus phenol. A clinical and neurophysiological study in thetreatment of ankle clonus. Eur J Phys Rehabil Med 2010;46:11-18.
31. Stampacchia G, Bradaschia E, Rossi B. Change of stretch reflex thresholdin spasticity: Effect of botulinum toxin injections. Arch Ital Biol2004;142:265-273. (Pubitemid 38796878)
32. Chen JJ, Wu YN, Huang SC, Lee HM, Wang YL. The use of a portablemuscle tone measurement device to measure the effects of botulinumtoxin type a on elbow flexor spasticity. Arch Phys Med Rehabil2005;86:1655-1660.
33. Lee HM, Chen JJ, Wu YN, Wang YL, Huang SC, Piotrkiewicz M. Timecourse analysis of the effects of botulinum toxin type a on elbow spasticitybased on biomechanic and electromyographic parameters. ArchPhys Med Rehabil 2008;89:692-699. (Pubitemid 351406328)
34. Murley GS, Menz HB, Landorf KB, Bird AR. Reliability of lowerlimb electromyography during overground walking: A comparisonof maximal- and sub-maximal normalisation techniques. J Biomech2010;43:749-756.
35. Lehman GJ, McGill SM. The importance of normalization in the interpretationof surface electromyography: A proof of principle. J ManipulativePhysiol Ther 1999;22:444-446. (Pubitemid 29474870)
36. Burden A. How should we normalize electromyograms obtained fromhealthy participants? What we have learned from over 25 years of research.J Electromyogr Kinesiol 2010;20:1023-1035.
37. Yang JF, Winter DA. Electromyographic amplitude normalizationmethods: Improving their sensitivity as diagnostic tools in gait analysis.Arch Phys Med Rehabil 1984;65:517-521. (Pubitemid 14030118)
38. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact ofbotulinum toxin type A on disability and carer burden due to armspasticity after stroke: A randomised double blind placebo controlledtrial. J Neurol Neurosurg Psychiatr 2000;69:217-221. (Pubitemid 30466027)
39. Arabadzhiev TI, Dimitrov VG, Dimitrova NA, Dimitrov GV. Interpretationof EMG integral or RMS and estimates of 'neuromuscularefficiency' can be misleading in fatiguing contraction. J ElectromyogrKinesiol 2010;20:223-232.
40. Hamjian JA, Walker FO. Serial neurophysiological studies of intramuscularbotulinum-A toxin in humans. Muscle Nerve 1994;17:1385-1392. (Pubitemid 24362810)
41. Calder K, Galea V, Wessel J, MacDermid J, MacIntyre N. Normalizationof EMG Amplitude: A Comparison of Different Methods Usedto Test Individuals with Arthritis of the Hand. American Society ofBiomechanics, Brown University, Providence, RI, USA, 2010.
42. Netto KJ, Burnett AF. Reliability of normalisation methods for EMGanalysis of neck muscles. Work 2006;26:123-130. (Pubitemid 43949815)
43. Arnall FA, Koumantakis GA, Oldham JA, Cooper RG. Between-daysreliability of electromyographic measures of paraspinal muscle fatigueat 40, 50 and 60% levels of maximal voluntary contractile force. ClinRehabil 2002;16:761-771. (Pubitemid 35276576)
44. De Luca C. The use of surface electromyography in biomechanics. JAppl Biomech 1997; 13:135-163. (Pubitemid 27246050)
45. Chen CL, Wong MK, Chen HC, Cheng PT, Tang FT. Correlation ofpolyelectromyographic patterns and clinical upper motor neuronsyndrome in hemiplegic stroke patients. Arch Phys Med Rehabil2000;81:869-875.
46. Crone C, Nielsen J, Petersen N, Ballegaard M, Hultborn H. Disynapticreciprocal inhibition of ankle extensors in spastic patients. Brain1994;117:1161-1168. (Pubitemid 24350547)
47. Cousins E, Ward A, Roffe C, Rimington L, Pandyan A. Does low-dosebotulinum toxin help the recovery of arm function when given earlyafter stroke? A phase II randomized controlled pilot study to estimateeffect size. Clin Rehabil 2010;24:501-513.
48. Farkas C, Hamilton-Wright A, Parsaei H, Stashuk DW. A reviewof clinical quantitative electromyography. Crit Rev Biomed Eng2010;38:467-485.
49. Daube JR, Rubin DI. Needle electromyography. Muscle Nerve2009;39:244-270.
50. Olver J, Esquenazi A, Fung VS, Singer BJ, Ward AB; Cerebral PalsyInstitute. Botulinum toxin assessment, intervention and aftercare forlower limb disorders of movement and muscle tone in adults: Internationalconsensus statement. Eur J Neurol 2010;17 Suppl 2:57-73.
51. Arimura K, Arimura Y, Takata Y, Nakamura T, Kaji R. Comparativeelectrophysiological study of response to botulinum toxin type B inJapanese and Caucasians. Mov Disord 2008;23:240-245. (Pubitemid 351311554)
52. Olesch CA, Greaves S, Imms C, Reid SM, Graham HK. Repeat botulinumtoxin-A injections in the upper limb of children with hemiplegia:A randomized controlled trial. Dev Med Child Neurol 2010;52:79-86.
53. Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.Botulinum toxin-Ain children with congenital spastic hemiplegiadoes not improve upper extremity motor-related function over rehabilitationalone: A randomized controlled trial. Neurorehabil NeuralRepair 2009;23:218-225.
54. Fuglevand AJ, Zackowski KM, Huey KA, Enoka RM. Impairment ofneuromuscular propagation during human fatiguing contractions atsubmaximal forces. J Physiol (Lond) 1993;460:549-572. (Pubitemid 23058065)
55. Moritani T, deVries HA. Neural factors versus hypertrophy in the timecourse of muscle strength gain. Am J Phys Med 1979;58:115-130. (Pubitemid 9210010)
56. Carroll TJ, Barton J, Hsu M, Lee M. The effect of strength training onthe force of twitches evoked by corticospinal stimulation in humans.Acta Physiol (Oxf) 2009;197:161-173.
57. Aagaard P, Simonsen EB, Andersen JL, Magnusson P, Dyhre-PoulsenP. Neural adaptation to resistance training: Changes in evoked V-waveand H-reflex responses. J Appl Physiol 2002;92:2309-2318. (Pubitemid 34666352)
58. Frigon A, Carroll TJ, Jones KE, Zehr EP, Collins DF. Ankle positionand voluntary contraction alter maximal M waves in soleus and tibialisanterior. Muscle Nerve 2007;35:756-766. (Pubitemid 46835117)
59. Goldfinger GH, Schoon CG. Reliability of the tonic vibratory reflex.Phys Ther 1978;58:46-50. (Pubitemid 8268948)
60. Calder KM, Hall LA, Lester SM, Inglis JG, Gabriel DA. Reliability ofthe biceps brachii M-wave. J Neuroeng Rehabil 2005;2:33.
61. Gruet M, Vallier JM, Mely L, Brisswalter J. Long term reliability ofEMG measurements in adults with cystic fibrosis. J Electromyogr Kinesiol2010;20:305- 312.
62. Zakaria D, Kramer JF, Harburn KL. Reliability of non-normalized andnormalized integrated EMG during maximal isometric contractionsin females. J Electromyogr Kinesiol 1996;6:129-135. (Pubitemid 26227824)
63. Mathur S, Eng JJ, MacIntyre DL. Reliability of surface EMG duringsustained contractions of the quadriceps. J Electromyogr Kinesiol2005;15:102-110. (Pubitemid 40092048)
64. de Araújo RC, Tucci HT, de Andrade R, Martins J, Bevilaqua-Grossi D,de Oliveira AS. Reliability of electromyographic amplitude values of theupper limb muscles during closed kinetic chain exercises with stableand unstable surfaces. J Electromyogr Kinesiol 2009;19:685-694.
65. Kollmitzer J, Ebenbichler GR, Kopf A. Reliability of surface electromyographicmeasurements. Clin Neurophysiol 1999;110:725-734.
66. Larsson B, Karlsson S, Eriksson M, Gerdle B. Test-retest reliability ofEMG and peak torque during repetitive maximum concentric kneeextensions. J Electromyogr Kinesiol 2003;13:281-287. (Pubitemid 36434397)
67. Levin MF, Hui-Chan C. Are H and stretch reflexes in hemiparesis reproducibleand correlated with spasticity? J Neurol 1993;240:63-71. (Pubitemid 23073193)
68. Phadke CP, Thompson FJ, Kukulka CG, Nair PM, Bowden MG, MadhavanS, Trimble MH, Behrman AL. Soleus H-reflex modulation aftermotor incomplete spinal cord injury: Effects of body position andwalking speed. J Spinal Cord Med 2010;33:371-378.
69. Voerman GE, Fleuren JF, Kallenberg LA, Rietman JS, Snoek GJ, HermensHJ. Patient ratings of spasticity during daily activities are onlymarginally associated with long-term surface electromyography. JNeurol Neurosurg Psychiatr 2009;80:175-181.
70. Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, BarnesM, et al.; BoTULS investigators. BoTULS: A multicentre randomisedcontrolled trial to evaluate the clinical effectiveness and cost-effectivenessof treating upper limb spasticity due to stroke with botulinumtoxin type A. Health Technol Assess 2010;14:1-113, iii.
71. Meythaler JM, Vogtle L, Brunner RC. A preliminary assessment of thebenefits of the addition of botulinum toxin a to a conventional therapyprogram on the function of people with longstanding stroke. ArchPhys Med Rehabil 2009;90:1453-1461.